Correlation Between Pasithea Therapeutics and Milestone Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Pasithea Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Milestone Pharmaceuticals.

Diversification Opportunities for Pasithea Therapeutics and Milestone Pharmaceuticals

0.13

Correlation Coefficient

Pasithea Therapeutics  Milestone Pharmaceuticals

Average diversification

The 3 months correlation between Pasithea and Milestone is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Milestone Pharmaceuticals

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 10.01 times more return on investment than Milestone Pharmaceuticals. However, Pasithea Therapeutics is 10.01 times more volatile than Milestone Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.2 per unit of risk. If you would invest  1.13  in Pasithea Therapeutics Corp on September 3, 2024 and sell it today you would earn a total of  0.90  from holding Pasithea Therapeutics Corp or generate 79.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	50.0%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Milestone Pharmaceuticals

Pasithea Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Milestone Pharmaceuticals

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pasithea Therapeutics and Milestone Pharmaceuticals

The main advantage of trading using opposite Pasithea Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.

The idea behind Pasithea Therapeutics Corp and Milestone Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.